France · Source-listed medicine information
France / CIS 67312509
SOLUVIT, lyophilisat pour usage parentéral
lyophilisat pour usage parentéral · intraveineuse
Source data retrieved: 2026-09-17. Clinical review is not yet available.
Product identity
At a glance
- Authorisation holder
- FRESENIUS KABI FRANCE
- Authorisation status
- Autorisation active
- Market status
- Commercialisée
- Country
- France
- Source reference
- CIS 67312509
Reported market status does not confirm current pharmacy stock.
From the official composition record
Ingredients & strength
Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.
| Ingredient | Strength / reference | Source role |
|---|---|---|
| BIOTINElyophilisat | 0,060 mgun flacon de lyophilisat | SAGroup 1 |
| ACIDE ASCORBIQUElyophilisat | 100,000 mgun flacon de lyophilisat | FTGroup 5 |
| ACIDE FOLIQUElyophilisat | 0,400 mgun flacon de lyophilisat | SAGroup 4 |
| ASCORBATE DE SODIUMlyophilisat | 113,000 mgun flacon de lyophilisat | SAGroup 5 |
| CYANOCOBALAMINElyophilisat | 0,005 mgun flacon de lyophilisat | SAGroup 6 |
| PYRIDOXINElyophilisat | 4,000 mgun flacon de lyophilisat | FTGroup 9 |
| RIBOFLAVINElyophilisat | 3,600 mgun flacon de lyophilisat | FTGroup 2 |
| NICOTINAMIDElyophilisat | 40,000 mgun flacon de lyophilisat | SAGroup 8 |
| CHLORHYDRATE DE PYRIDOXINElyophilisat | 4,900 mgun flacon de lyophilisat | SAGroup 9 |
| ACIDE PANTOTHÉNIQUElyophilisat | 15,000 mgun flacon de lyophilisat | FTGroup 11 |
| PHOSPHATE SODIQUE DE RIBOFLAVINElyophilisat | 4,900 mgun flacon de lyophilisat | SAGroup 2 |
| MONONITRATE DE THIAMINElyophilisat | 3,100 mgun flacon de lyophilisat | SAGroup 7 |
| SODIUM (PANTOTHÉNATE DE)lyophilisat | 16,500 mgun flacon de lyophilisat | SAGroup 11 |
| THIAMINElyophilisat | 2,500 mgun flacon de lyophilisat | FTGroup 7 |
Pack references
Presentations (2)
CIP13 3400935652119
Présentation active · Déclaration de commercialisationCIP13 3400936766952
Présentation active · Déclaration de commercialisationFrom the French medicines authority
Official documents
The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.
Open the official product entryBDPM · CIS 67312509 · Opens in a new tabCheck the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.
Where this information comes from
Sources & dates
Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.
| Source file | Retrieved | Source file modified |
|---|---|---|
| fr_products.txt | Not supplied | |
| fr_composition.txt | Not supplied | |
| fr_packs.txt | Not supplied |
Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.
Our sources and review process →